tradmap

MKSI Financials MKS Instruments

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 11.0% per year over the past 5 years.
  • Net income has grown slower than revenue (-3.4% vs 11.0% per year).
  • Operating margin has contracted, at 13.4% in the latest year.
  • Free cash flow has grown 3.0% per year over the past 5 years.

Financial health

  • Total debt ($4.2B) exceeds cash ($418M); net debt is $3.8B.
  • Total debt has grown faster than revenue (38.3% vs 11.0% per year).
  • Operating income covered interest expense 2.5× in the latest year, down from 16× 5 years ago.
  • Total debt is 4.8× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 20.0% of earnings and 11.9% of free cash flow.
  • The dividend has grown 6.0% per year over the past 5 years.
Revenue & net income
-$2B $1B $4B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-51% -2% 48% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-74% -27% 21% 0% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $277M $553M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $2B $5B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$5B -$291M $4B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $3.9B $295M 46.7% 13.4% 10.8% 3.4% $497M $4.2B $418M
2024 $3.6B $190M 47.6% 13.9% 8.2% 2.2% $410M $4.5B $420M
2023 $3.6B -$1.8B 45.3% -42.9% -74.5% -20.2% $232M $4.8B $507M
2022 $3.5B $333M 43.6% 17.4% 7.4% 2.9% $365M $4.9B —
2021 $3.0B $551M 46.8% 23.7% 19.1% 12.1% $553M $817M —
2020 $2.3B $350M 45.0% 19.5% 14.8% 9.0% $428M $830M —
2019 $1.9B $140M 43.7% 11.6% 6.9% 4.1% $181M $884M —
2018 $2.1B $393M 47.2% 23.8% 21.0% 15.0% $351M $348M $644M
2017 $1.9B $339M 46.5% 21.2% 21.3% 14.0% $324M $393M $334M
2016 $1.3B $105M 43.7% 12.1% 8.4% 4.7% $161M $612M $229M
2015 — $122M — — 10.5% 9.6% — — $228M
2014 — $116M — — 10.7% 9.5% — — $305M
2013 — $36M — — 3.5% 2.9% $64M — $289M
2012 — $48M — — 4.7% 4.2% $119M — $288M
2011 — $130M — — 13.1% 11.4% $140M — $313M

Valuation over time

How the market has priced MKSI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 51.3 102.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 3.9 7.7 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 0.6 1.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is MKSI growing its revenue and profit?

Over the past 5 years, MKS Instruments's revenue has grown 11.0% per year, and net income declined 3.4% per year. These are computed facts, not advice.

How much debt does MKSI have?

As of FY2025, MKS Instruments reported $4.2B of total debt against $418M of cash; operating income covered interest expense 2.5×.

What is MKSI's profit margin?

In FY2025, gross margin was 46.7%, operating margin 13.4%, and net margin 7.5%.

What is MKSI's P/E ratio?

MKS Instruments's P/E (TTM) is 30.19 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the MKSI stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 45.0× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.